$6.12
-0.13 (-2.08%)
Halozyme Therapeutics, Inc. (HALO)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

RSS Headlines
Fool UK